Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000342013 | SCV000333914 | uncertain significance | not provided | 2015-08-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081453 | SCV001008384 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000342013 | SCV001831581 | benign | not provided | 2016-01-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000342013 | SCV002063940 | likely benign | not provided | 2021-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003165726 | SCV003887493 | likely benign | Cardiovascular phenotype | 2023-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |